These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6213379)

  • 1. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
    Kuhlman DS; Callen JP
    Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a new erythromycin solution for acne vulgaris.
    Rivkin L; Rapaport M
    Cutis; 1980 May; 25(5):552-5. PubMed ID: 6445816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris.
    Leyden JJ; Shalita AR; Saatjian GD; Sefton J
    J Am Acad Dermatol; 1987 Apr; 16(4):822-7. PubMed ID: 2952685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
    Schachner L; Pestana A; Kittles C
    J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
    Puhvel SM
    Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new salt of erythromycin (A-137 or erythromycin lauryl sulfate) in the topical treatment of acne].
    Pérez López M; Moragas Viñas JM
    Med Cutan Ibero Lat Am; 1982; 10(3):151-8. PubMed ID: 6218350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison.
    Shahlita AR; Smith EB; Bauer E
    Arch Dermatol; 1984 Mar; 120(3):351-5. PubMed ID: 6230999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris.
    Goltz RW; Coryell GM; Schnieders JR; Neidert GL
    Cutis; 1985 Sep; 36(3):265-8. PubMed ID: 2932307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
    Schmidt JB; Neumann R; Fanta D; Raab W
    Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
    Braathen LR
    Scand J Infect Dis Suppl; 1984; 43():71-5. PubMed ID: 6242073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris.
    Ellis CN; Gammon WR; Stone DZ; Heezen-Wehner JL
    Cutis; 1988 Sep; 42(3):245-7. PubMed ID: 2971512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin 2 percent gel in the treatment of acne vulgaris.
    Pochi PE; Bagatell FK; Ellis CN; Stoughton RB; Whitmore CG; Saatjian GD; Sefton J
    Cutis; 1988 Feb; 41(2):132-6. PubMed ID: 2964344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
    Rapaport M; Puhvel SM; Reisner RM
    Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris.
    Katsambas A; Towarky AA; Stratigos J
    Br J Dermatol; 1987 Mar; 116(3):387-91. PubMed ID: 2952156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
    NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
    Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.